Correlation Between Tandem Diabetes and Alvotech

Can any of the company-specific risk be diversified away by investing in both Tandem Diabetes and Alvotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tandem Diabetes and Alvotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tandem Diabetes Care and Alvotech, you can compare the effects of market volatilities on Tandem Diabetes and Alvotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tandem Diabetes with a short position of Alvotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tandem Diabetes and Alvotech.

Diversification Opportunities for Tandem Diabetes and Alvotech

0.6

Correlation Coefficient

Tandem Diabetes  Alvotech

Poor diversification

The 3 months correlation between Tandem and Alvotech is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Tandem Diabetes Care and Alvotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alvotech and Tandem Diabetes is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tandem Diabetes Care are associated (or correlated) with Alvotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alvotech has no effect on the direction of Tandem Diabetes i.e., Tandem Diabetes and Alvotech go up and down completely randomly.

Pair Corralation between Tandem Diabetes and Alvotech

Given the investment horizon of 90 days Tandem Diabetes Care is expected to generate 1.58 times more return on investment than Alvotech. However, Tandem Diabetes is 1.58 times more volatile than Alvotech. It trades about 0.07 of its potential returns per unit of risk. Alvotech is currently generating about 0.01 per unit of risk. If you would invest  3,063  in Tandem Diabetes Care on November 29, 2024 and sell it today you would earn a total of  296.00  from holding Tandem Diabetes Care or generate 9.66% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Tandem Diabetes Care  vs.  Alvotech

Tandem Diabetes Care

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Tandem Diabetes Care are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental indicators, Tandem Diabetes may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Alvotech

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Alvotech are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Alvotech is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Tandem Diabetes and Alvotech

The main advantage of trading using opposite Tandem Diabetes and Alvotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tandem Diabetes position performs unexpectedly, Alvotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alvotech will offset losses from the drop in Alvotech's long position.

The idea behind Tandem Diabetes Care and Alvotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.